TY - JOUR AU - Tabák, Ádám AU - Tamás, Gyula AU - Zgibor, J AU - Wilson, R AU - Becker, D AU - Kerenyi, Z AU - Orchard, TJ TI - Targets and reality: a comparison of health care indicators in the U.S. (Pittsburgh Epidemiology of Diabetes Complications Study) and Hungary (DiabCare Hungary) JF - DIABETES CARE J2 - DIABETES CARE VL - 23 PY - 2000 IS - 9 SP - 1284 EP - 1289 PG - 6 SN - 0149-5992 DO - 10.2337/diacare.23.9.1284 UR - https://m2.mtmt.hu/api/publication/1681035 ID - 1681035 AB - OBJECTIVE: In the U.S., both primary care and specialist physicians share in the care of type 1 diabetic patients, often in an informal collaboration. In Hungary, however, type 1 diabetic patients are generally managed in special centralized diabetes units. These different treatment settings may lead to different health care practices and outcomes. To determine if this is true, diabetes care indicators and complications were compared across representative study populations from the 2 countries. RESEARCH DESIGN AND METHODS: The Pittsburgh Epidemiology of Diabetes Complications Study (EDC) is a prospective cohort of childhood-onset type 1 diabetic patients. DiabCare Hungary, a multicenter cross-sectional study, was developed for quality control purposes and provides a nationwide data set of diabetic patients. We identified 2 comparable populations (EDC, n = 416; DiabCare, n = 405) in terms of age (> or =14 years) and age at onset (<17 years). RESULTS: EDC patients were less likely to receive diabetes education (P<0.0001), see an ophthalmologist (P<0.0001), be treated by diabetologists (P<0.0001), or perform self-monitoring of blood glucose (P<0.0001). They were more likely to use conservative insulin regimens (i.e., 1-2 injections/day, P<0.0001) and have a higher glycated hemoglobin (P< 0.0001). DiabCare patients more often experienced severe hypoglycemia (P<0.01) and had a lower prevalence of proliferative retinopathy (P<0.0001), legal blindness (P<0.05), and albuminuria (> or =30 mg/day P<0.01). No significant differences in macrovascular complications were seen, although rates were generally low CONCLUSIONS: These data suggest that the 2 populations differ by their diabetes care practices, degree of glycemic control, and microvascular complication status. LA - English DB - MTMT ER - TY - JOUR AU - Collado-Mesa, F AU - Colhoun, HM AU - Stevens, LK AU - Boavida, J AU - Ferriss, JB AU - B, Karamanos AU - Kempler, Péter AU - Michel, G AU - Roglic, G AU - Fuller, JH ED - The, Eurodiab Iddm Complications Study Group / Collaborative Organization TI - Prevalence and management of hypertension in Type 1 diabetes mellitus in Europe. the EURODIAB IDDM Complications Study TS - the EURODIAB IDDM Complications Study JF - DIABETIC MEDICINE J2 - DIABETIC MED VL - 16 PY - 1999 IS - 1 SP - 41 EP - 48 PG - 9 SN - 0742-3071 DO - 10.1046/j.1464-5491.1999.00007.x UR - https://m2.mtmt.hu/api/publication/1720529 ID - 1720529 N1 - LA - English DB - MTMT ER -